Wednesday, December 10, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

N-Able Maintains Analyst Confidence Despite Executive Share Sale

Robert Sasse by Robert Sasse
September 7, 2025
in Analysis, Insider Trading, Tech & Software
0
N-Able Stock
0
SHARES
183
VIEWS
Share on FacebookShare on Twitter

Market experts continue to endorse N-Able shares with a “Moderate Buy” consensus recommendation, even as the company’s Executive Vice President recently divested a substantial portion of his holdings. This divergence between insider action and analyst outlook presents investors with a compelling puzzle.

Strong Quarterly Performance Underpins Optimism

The bullish stance from Wall Street follows N-Able’s impressive second-quarter results for fiscal 2025. The cloud software specialist reported earnings per share of $0.11, significantly surpassing the $0.09 consensus estimate. Revenue reached $131.25 million, exceeding projections and demonstrating robust year-over-year growth of 9.9 percent.

Five equity researchers covering the company maintain positive ratings, with their collective price target of $9.31 suggesting approximately 18 percent upside from current trading levels. Individual forecasts range from $8.50 to $10.00 per share.

Insider Transaction and Revised Estimates

Despite this optimism, investors noted a notable insider transaction in mid-August. Michael I. Adler, an executive vice president at the company, sold shares valued at nearly $245,000. Such disposals by senior management often attract scrutiny as potential signals about a company’s prospects.

Should investors sell immediately? Or is it worth buying N-Able?

Additionally, analysts have slightly tempered their full-year expectations over the past month. The consensus EPS estimate for fiscal 2025 has been adjusted downward from $0.15 to $0.14.

Strategic Expansion and Maintained Guidance

N-Able continues to execute its growth strategy, particularly in the cybersecurity domain. The November 2024 acquisition of Adlumin enhanced its offerings with cloud-native XDR and MDR solutions. This strategic move is anticipated to contribute to annual recurring revenue (ARR) and cash flow growth by the fourth quarter of 2025.

Management has reaffirmed its full-year 2025 outlook, projecting revenue between $500 million and $503 million. This would represent growth of 7 to 8 percent compared to the previous year.

Upcoming Catalyst and Market Watch

The investment community now turns its attention to the upcoming Q3 2025 earnings release scheduled for November 6. This report will provide crucial insight into whether the analysts’ confidence is well-founded or if the insider’s decision to reduce exposure might indicate challenges ahead. The market will be watching closely to see which perspective proves accurate.

Ad

N-Able Stock: Buy or Sell?! New N-Able Analysis from December 10 delivers the answer:

The latest N-Able figures speak for themselves: Urgent action needed for N-Able investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 10.

N-Able: Buy or sell? Read more here...

Tags: N-Able
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Civista Bancshares Stock
Analysis

Civista Bancshares Shares Approach a Critical Technical Juncture

December 9, 2025
Marine Products Stock
Analysis

Marine Products Stock: A Potential Shift in Momentum?

December 9, 2025
Shenandoah Telecommunications Stock
Analysis

Shentel’s Strategic Pivot: Can Debt Refinancing and Fiber Push Reinvigorate Shares?

December 9, 2025
Next Post
Nurix Therapeutics Inc Stock

Nurix Therapeutics Stock Surges on Renewed Investor Confidence

PayPal Stock

Venmo Emerges as PayPal's Unexpected Growth Engine

Micron Stock

Micron Stock Surges to Record High on Strong AI Demand

Recommended

Digital market connection

Purpose-Driven Marketing: How Companies Are Leveraging Their Platforms to Create Social Impact

2 years ago
EOG stock news

Cravens & Co Advisors LLC Acquires Stake in Cenovus Energy Inc.: Promising Growth Potential for the Leading Integrated Energy Company

2 years ago
Kohl's Stock

Kohl’s Defies Retail Sector Gloom with Stunning Quarterly Performance

3 months ago
Air Products Stock

Industrial Gas Giant Navigates Strategic Shift Amid Hydrogen Ambitions

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Sysco Shares Face Persistent Market Headwinds

ASML Faces Scrutiny Over Semiconductor Equipment Sales to Chinese Entities

Sellas Life Sciences Shares Surge on Encouraging Clinical Trial Data

Major Funds Accumulate Sherwin-Williams Shares Amid Price Weakness

Zimmer Biomet Shares Face Selling Pressure Amid Divergent Investor Moves

Diverging Views on The Trade Desk’s Market Trajectory

Trending

Civista Bancshares Stock
Analysis

Civista Bancshares Shares Approach a Critical Technical Juncture

by Robert Sasse
December 9, 2025
0

Shares of Civista Bancshares are currently trading at a pivotal technical level, closing Monday's session at $23.46....

Marine Products Stock

Marine Products Stock: A Potential Shift in Momentum?

December 9, 2025
Shenandoah Telecommunications Stock

Shentel’s Strategic Pivot: Can Debt Refinancing and Fiber Push Reinvigorate Shares?

December 9, 2025
Sysco Stock

Sysco Shares Face Persistent Market Headwinds

December 9, 2025
Asml Stock

ASML Faces Scrutiny Over Semiconductor Equipment Sales to Chinese Entities

December 9, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Civista Bancshares Shares Approach a Critical Technical Juncture
  • Marine Products Stock: A Potential Shift in Momentum?
  • Shentel’s Strategic Pivot: Can Debt Refinancing and Fiber Push Reinvigorate Shares?

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com